drugset / Trial / NCT01405989

To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)

NCT01405989

Phase 1 Completed 26 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The primary objective of this study is to determine the effect of ketoconazole on the blood concentrations of darexaban and its metabolites (drug degradation products). The secondary objective of the study is to evaluate the safety and tolerability of a single dose of darexaban alone and when administered together with ketoconazole.

Timeline

Start
2010-01
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule Oral
Subject darexaban Small molecule Oral

Indications

No indication recorded.